Sabin Vaccine Institute Receives up to $ 6.3 Million from
Washington, DC, May 17, 2022 (GLOBE NEWSWIRE) – The Sabin Vaccine Institute was awarded up to $ 6.3 million from…
An atlas of human immune cells across tissues
In a recent article published in the Science journal, researchers demonstrated tissue-specific immune cell characteristics in humans by performing cross-tissue…
Evaluating SARS-CoV-2 infection risk in indoor environments
In a recent study under review at the Scientific Reports journal and posted to the Research Square* preprint server, researchers…
Australian researchers show solar power can be generated at night
It may sound like a contradiction in terms, but Australian researchers have made a major breakthrough in “night-time solar” technology.…
‘Steele dossier’ source up next in Durham probe of Trump-Russia investigations
Monday’s trial of former Hillary Clinton campaign lawyer Michael Sussmann is set to be followed by special counsel John Durham’s…
People with young-onset Alzheimer’s experience faster symptom progression than older counterparts
People diagnosed with Alzheimer’s disease at a younger age will experience faster symptom progression than their older counterparts, a new…
Ocular toxoplasmosis found to be common among Australians
One in 150 Australians have retinal scars caused by the Toxoplasma parasite, according to new Flinders University analysis. Eye scan…
Stressed Out? Sharing That With Others May Make You Seem More Likable
Humans behave in strange ways. We readily reveal our inner feelings during moments of weakness, which does not seem like…
Investigating effectiveness of mRNA booster against SARS-CoV-2 Omicron in individuals primed with mRNA or inactivated virus vaccines
Scientists have developed vaccines at an unprecedented rate to protect individuals from severe acute respiratory syndromes coronavirus-2 (SARS-CoV-2) infection, which…
Super-antibody UT28K shows broad-spectrum activity against SARS-CoV-2 variants
Even as the Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to circulate, causing thousands of…